vendredi 7 avril 2017
GSK recalls nearly 600,000 asthma inhalers in U.S.
GSK Plc is voluntarily recalling more than 593,000 Ventolin asthma inhalers from U.S. hospitals, pharmacies, retailers and wholesalers due to a defect that may cause them to deliver fewer doses of the medicine than indicated.
Related Posts:
15.5 million Americans now surviving cancer: report- Listeria concern prompts recall of certain Spitz, Quaker and CLIF Bar products
- Listeria concern prompts recall of certain Spitz, Quaker and CLIF Bar products
- Gender-confirming surgeries will now be covered in New Brunswick
- 15.5 million Americans now surviving cancer: report
Articles
0 comments:
Enregistrer un commentaire